Gencor Industries In (GENC) 14.81 $GENC Gencor posts 2Q

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2016 at 10:07 AM

Gencor Industries In (GENC) 14.81 $GENC

Gencor posts 2Q profit
Automated Insights - Mon May 09, 6:36PM CDT
ORLANDO, Fla. (AP) _ Gencor Industries Inc. (GENC) on Monday reported fiscal second-quarter profit of $1.6 million.
GENC: 14.81 (-0.06)

Gencor Releases Second Quarter Fiscal 2016 Results
GlobeNewswire - Mon May 09, 3:30PM CDT
Gencor Industries, Inc. (Nasdaq:GENC) announced today net revenue for the quarter ended March 31, 2016 increased 60.5% to $22.1 million from $13.8 million for the quarter ended March 31, 2015. Gross margin was 24.6% for the quarter ended March 31, 2016 compared with 26.4% for the quarter ended March 31, 2015. Selling, general and administrative ("SG&A"

expenses increased $414,000 to $2,190,000 for the quarter ended March 31, 2016, from $1,776,000 for the quarter ended March 31, 2015. Increased staffing along with higher sales commissions contributed to the increased SG&A expenses. Operating income for the quarter ended March 31, 2016 was $2.9 million compared to $1.5 million for the quarter ended March 31, 2015.
GENC: 14.81 (-0.06)

Gencor Industries Shares Up 13.9% Since SmarTrend's Buy Recommendation (GENC)
Comtex SmarTrend(R) - Tue Mar 08, 10:15AM CST
SmarTrend identified an Uptrend for Gencor Industries (NASDAQ:GENC) on February 10th, 2016 at $12.73. In approximately 4 weeks, Gencor Industries has returned 13.90% as of today's recent price of $14.50.
GENC: 14.81 (-0.06)

Gencor Releases First Quarter Fiscal 2016 Results
GlobeNewswire - Wed Feb 10, 8:56AM CST
Gencor Industries, Inc. (Nasdaq:GENC) announced today net revenues increased 111% to $13.3 million for the quarter ended December 31, 2015 compared to $6.3 million for the quarter ended December 31, 2014. Gross margins increased significantly from 5.5% for the quarter ended December 31, 2014 to 24.8% for the quarter ended December 31, 2015, due to improved productivity, increased revenues and cost absorption, process improvements, and lower commodity prices. Product engineering and development expenses increased $53,000 to $382,000 for the quarter ended December 31, 2015 due to increased staffing and payroll. Selling, general and administrative expenses increased $135,000 or 8.2% to $1,785,000 for the quarter ended December 31, 2015. Sales commissions and other operating expenses increased due to the higher revenues. Operating income for the quarter ended December 31, 2015 was $1.1 million, compared to an operating loss of $(1.6) million for the quarter ended December 31, 2014.
GENC: 14.81 (-0.06)

Gencor Industries Has Returned 24.2% Since SmarTrend Recommendation (GENC)
Comtex SmarTrend(R) - Wed Jan 13, 10:00AM CST
SmarTrend identified an Uptrend for Gencor Industries (NASDAQ:GENC) on October 16th, 2015 at $9.95. In approximately 3 months, Gencor Industries has returned 24.22% as of today's recent price of $12.36.
GENC: 14.81 (-0.06)

16.3% Return Seen to Date on SmarTrend Gencor Industries Call (GENC)
Comtex SmarTrend(R) - Wed Jan 06, 9:31AM CST
SmarTrend identified an Uptrend for Gencor Industries (NASDAQ:GENC) on October 16th, 2015 at $9.95. In approximately 3 months, Gencor Industries has returned 16.30% as of today's recent price of $11.57.
GENC: 14.81 (-0.06)

Shares of GENC Up 16.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Dec 28, 9:53AM CST
SmarTrend identified an Uptrend for Gencor Industries (NASDAQ:GENC) on October 16th, 2015 at $9.95. In approximately 2 months, Gencor Industries has returned 16.58% as of today's recent price of $11.60.
GENC: 14.81 (-0.06)

29.1% Return Seen to Date on SmarTrend Gencor Industries Call (GENC)
Comtex SmarTrend(R) - Thu Dec 10, 4:49PM CST
SmarTrend identified an Uptrend for Gencor Industries (NASDAQ:GENC) on October 16th, 2015 at $9.95. In approximately 2 months, Gencor Industries has returned 29.15% as of today's recent price of $12.85.
GENC: 14.81 (-0.06)

Gencor reports 4Q loss
Automated Insights - Tue Dec 08, 1:15PM CST
ORLANDO, Fla. (AP) _ Gencor Industries Inc. (GENC) on Tuesday reported a loss of $2.2 million in its fiscal fourth quarter.
GENC: 14.81 (-0.06)

Gencor Releases Fourth Quarter and Fiscal Year 2015 Results
GlobeNewswire - Tue Dec 08, 12:20PM CST
Gencor Industries, Inc., (NASDAQ:GENC) announced today net revenue for the quarter ended September 30, 2015 increased 69.4% to $8.3 million compared to $4.9 million for the quarter ended September 30, 2014. Gross margin as a percentage of net revenue increased 110.8% to 13.7% for the quarter ended September 30, 2015 from 6.5% for the quarter ended September 30, 2014. The increase in gross margins was due to higher revenue and a reduction in raw material costs.
GENC: 14.81 (-0.06)

Equity Market Movement at a Glance - Research on Ultralife, First Acceptance, Titan Pharmaceuticals and Gencor Industries
ACCESSWIRE - Wed Dec 02, 7:15AM CST
NEW YORK, NY / ACCESSWIRE / December 02, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Ultralife Corp. (NASDAQ: ULBI), First Acceptance Corp. (NYSE: FAC), Titan Pharmaceuticals Inc. (NASDAQ: TTNP) and Gencor Industries Inc. (NASDAQ: GENC). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ULBI: 4.98 (-0.37), GENC: 14.81 (-0.06), TTNP: 6.43 (+0.34), FAC: 1.57 (+0.03)

8.4% Return Seen to Date on SmarTrend Gencor Industries Call (GENC)
Comtex SmarTrend(R) - Tue Aug 25, 9:55AM CDT
SmarTrend identified a Downtrend for Gencor Industries (NASDAQ:GENC) on August 6th, 2014 at $10.18. In approximately 13 months, Gencor Industries has returned 8.40% as of today's recent price of $9.32.
GENC: 14.81 (-0.06)

Gencor Releases Third Quarter Fiscal 2015 Results
GlobeNewswire - Wed Aug 05, 12:53PM CDT
Gencor Industries, Inc. (Nasdaq:GENC) announced today net revenue for the quarter ended June 30, 2015 increased 3.7% to $10.9 million from $10.6 million for the quarter ended June 30, 2014. Gross margin increased to 21.9% for the quarter ended June 30, 2015 from 21.6% for the quarter ended June 30, 2014. Selling, general and administrative expenses increased $146,000 to $1,703,000 for the quarter ended June 30, 2015. Operating income for the quarter ended June 30, 2015 was $345,000 compared to $372,000 for the quarter ended June 30, 2014.
GENC: 14.81 (-0.06)

Gencor reports lower net income of USD1.2m in Q2 fiscal 2015
M2 - Mon May 11, 5:33AM CDT
Machinery company Gencor Industries (NasdaqGM:GENC) disclosed on Friday that it recorded net income of USD1.2m (USD0.12 per basic and diluted share) for the second quarter ended 31 March 2015.
GENC: 14.81 (-0.06)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ortho Molecular and HANS: Streamlining Functional Medicine

Functional Medicine Gets a Tech Boost The world of functional medicine just got a major shot in the arm, courtesy of an intriguing alliance between Ortho Molecular Products and HANS.FM. First of all, let's address the elephant in the room: clinicians in this field aren't exactly on a coffee break. They’re buried under mountains of paperwork, often spending hours just...

CURE Intl and Thoughtworks Step Into Digital Era

Pushing Paper Out, Digitizing In In a world where tech is king, why were hospitals—crucial, life-saving institutions—still bogged down by dusty folders and ink smudges? Well, not anymore for CURE International, not with Thoughtworks stepping up to the plate. This ain't just swapping paper for pixels; it's a lifeline for kids getting world-class surgical care without...

Jinko Solar Joins B20 Summit: Energy Forefront Focus

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Agilyx's Q3 Update: GreenDot Shines Amid Mixed Results

Peeking into Agilyx's Financial Odyssey Just as I sip my morning coffee pondering the highs and lows of the market, here comes Agilyx ASA splashing some liquidity on the scene. The Q3 report paints the company in various shades—from solid greens to hesitant reds. Nothing like the thrill of untangling mixed results over a quiet day, huh? GreenDot's Climb to Profitability...

Inflatable Wonders Turn Christmas into a Hoot at Lowe's

Inflatables Bringing the Cheer (and Laughs) Well, it's that season again—where decorations either have us grumbling at the electric bill or chuckling at the lawn art. Lowe's has teamed up with Gemmy to serve a heaping platter of holiday giggles this year. They've rolled out a quirky lineup of inflatables that go from shivering Highland cows to dinosaurs and elves....

LG Innotek Scores Hat Trick with CES Innovation Wins

LG Innotek's Lighting Triumph Here we go again, LG Innotek just snagged their third CES Innovation Award in a row, this time for their cutting-edge vehicle lighting module, Nexlide C+. It's one for the books—breaking into the 2027 CES spotlight with innovative tech that not only grabs the eyes but could also steal the hearts of investors willing to bet on the future of...

RF MEDICAL Expands into Europe with New CE Certification

RF MEDICAL Secures CE Marking for Mi-BLATOR™ Just when you think the European medical device market's hit its saturation point, RF MEDICAL decides to kick the door open with their Mi-BLATOR™ microwave ablation system. This ain't just another plastic gadget, folks; it's got that shiny new CE marking under the European Union's Medical Device Regulation (MDR). Now, what...

BD Sets Stage for Investor Day in December 2026

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Centrus Energy Welcomes Nuclear Veteran to Leadership

Navigating a New Era at Centrus When you hear about seasoned veterans stepping up to the plate in the energy sector, it's time to perk up your ears. Centrus Energy (NYSE:LEU), a big player in nuclear fuel, just added Kevin Graney to their Board of Directors. This isn't your run-of-the-mill appointment; it packs nearly three decades of nuclear tech and national security...